Jeffrey Ubben is the founder of one of the hedge funds we track, ValueAct Capital Management. Recently, this hedge fund disclosed all of its equities held at the end of the second quarter of the year.
Because it’s important to track the market-beating potential of hedge fund sentiment, let’s take a look at the most valuable picks included in the most recent 13F of ValueAct Capital. As follows, highlights from our list are Microsoft Corporation (NASDAQ:MSFT) and Motorola Solutions Inc (NYSE:MSI).
Microsoft Corporation (NASDAQ:MSFT) is represented in ValueAct’s equity portfolio by an almost $2.0 billion position. The hedge fund’s stake in Microsoft contains 57.75 million shares, and even though it is not as big as the stake of some of the bigger players from the hedge fund world, it is important to mention that the stake accounts for about 20% of ValueAct’s total 13F. During the second quarter, the hedge fund added almost 25 million shares to its position in Microsoft Corporation (NASDAQ:MSFT), whose stock has returned about 19% since the beginning of the year.
In the second position is Motorola Solutions Inc (NYSE:MSI), in which ValueAct holds 28.9 million shares, worth about $1.7 billion. In comparison with the first quarter of 2013, the number of shares remained unchanged, although the value of the stake declined from the previous value of almost $1.9 billion. The year-to-date return of Motorola Solutions Inc (NYSE:MSI) is slightly above 2.4%, while the forward P/E ratio and the PEG ratio amount to about 14.3 and 1.2x respectively.
Next on the list is a company from the healthcare sector. ValueAct disclosed ownership of 18.9 million shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), the value of the stake being over $1.6 billion. During the April-June period, ValueAct’s position in Valeant Pharmaceuticals rose by about 1.3 million shares. Another over-a-billion stake in Ubben’s equity portfolio is in Adobe Systems Incorporated (NASDAQ:ADBE). The position contains 31.3 million shares, worth $1.4 billion, unchanged over the quarter. The fifth-largest stake held by Valueact, involves 32 million shares of CBRE Group Inc (NYSE:CBG), worth $747.8 million, the position remaining almost flat since the end of March.
On the whole, the 13F portfolio of Jeffrey Ubben’s ValueAct Capital contains stakes in 14 companies and has a total value of $9.7 billion. Since Valueact Capital is an important player in the hedge fund world, we will keep you updated regarding its latest moves and investment plays.